← Back

Wire · opportunities

AIRS Medical Receives FDA 510(k) Clearance for SwiftSight® Body Composition

Published

6 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at prnewswire.com →

◆ Verified

Fusion42 · 7 October 2026 · Fusion42 review

AIRS Medical received FDA 510(k) clearance for SwiftSight Body Composition, an AI-powered MRI solution that standardizes body composition analysis to quantify muscle, fat, and liver fat with a quick scan and automated reporting. The product aims to help imaging organizations expand MRI services and create new revenue streams by adding quantitative body composition analysis without increasing operational complexity.

This Wire brief sits within Fusion42's coverage of Medtech, and 3 sources have reported it between 6 Oct 2026 and 7 Oct 2026.

◆ ◆ The Wire takeaway

You can now add a repeatable, quantitative body composition service to MRI programs without disrupting workflow or infrastructure. Imaging providers face fresh chances to expand offerings and revenue through fast AI analysis that works across multiple sites uniformly.

◆ Coverage

3 sources · first reported 6 Oct 2026 · latest 7 Oct 2026

◆ Related on Wire

◆ Topics

Medtechai-powered-mribody-compositionfda-clearancemedical-imaginghealthcare-innovation